Servicios Personalizados
Revista
Articulo
Indicadores
Citado por SciELO
Accesos
Links relacionados
Citado por Google
Similares en SciELO
Similares en Google
Compartir
Revista Colombiana de Reumatología
versión impresa ISSN 0121-8123
Resumen
BARAHONA-CORREA, Julián et al. Pulmonary involvement in Sjögren's syndrome. Rev.Colomb.Reumatol. [online]. 2020, vol.27, suppl.2, pp.109-124. Epub 07-Sep-2021. ISSN 0121-8123. https://doi.org/10.1016/j.rcreu.2020.06.013.
Sjögren’s syndrome is a systemic autoimmune disease with a high burden for the individual, as well as society. Pulmonary compromise presents with a myriad of manifestations that influence patient quality of life and mortality risk. An integrated dynamic approach by a multidisciplinary diagnostic discussion team that includes experts in chest diseases, rheumatology, radiology, and pathology has the potential to improve the identification, management strategies, and outcomes. Although early recognition of patients at high risk is essential, there is currently a lack of reliable biomarkers. Pharmacological therapies are based on immunomodulation, although the evidence to support their use is of low quality. Increasing awareness and training among healthcare professionals may reduce a delayed access to specialized assessment.
Palabras clave : Sjögren’s syndrome; Respiratory system; Lung; Interstitial lung diseases; Interdisciplinary communication.